The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age.

Carrascosa, A

The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age. [electronic resource] - The Journal of clinical endocrinology and metabolism Mar 2008 - 764-70 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0021-972X

10.1210/jc.2007-2180 doi


Birth Weight
Body Height--drug effects
Child
Child, Preschool
Exons
Female
Genotype
Growth Disorders--drug therapy
Growth Hormone--therapeutic use
Hormone Replacement Therapy
Human Growth Hormone--blood
Humans
Infant, Newborn
Male
Polymorphism, Genetic
Receptors, Somatotropin--genetics
Retrospective Studies